
Women's Health Went Home. Nanopath Bet $25 Million On The Exam Room
Forbes - Innovation
16 lis 2026, 12:07Tech
1 min read
Nanopath's co-CEOs have bet $25 million on a 15-minute in-office test as a 2026 study revealed half of women without vaginal infections received unnecessary treatment.
The investment comes amid growing concerns about overtreatment in women's healthcare.
New Diagnostic Approach
Nanopath's 15-minute in-office test promises to deliver rapid results, potentially revolutionizing how gynecological exams are conducted and reducing unnecessary treatments.
Related
Article written by AI
Z.ai GLM-4.5-FlashFree